Analysis of IDH and EGFR as biomarkers in glioblastoma multiforme: A case-control study
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Jordan University of Science and Technology
This publication has 44 references indexed in Scilit:
- Epidemiology of Brain and Other Central Nervous System Cancers in the North Africa and Middle East Region: A Systematic Analysis of the Global Burden of Disease Study 1990–2019World Neurosurgery, 2022
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaJAMA Oncology, 2022
- Patients’ Survival with Astrocytoma After Treatment: a Systematic Review and Meta-analysis of Clinical Trial StudiesIndian Journal of Surgical Oncology, 2022
- Glioblastoma in adolescents and young adults: An age-based comparative study from Jordan over a 17-year periodCancer Epidemiology, 2021
- Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma CellsCell Reports, 2018
- Emerging functions of the EGFR in cancerMolecular Oncology, 2017
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- Androgen receptor signaling regulates growth of glioblastoma multiforme in menTumor Biology, 2014
- Improved survival time trends for glioblastoma using the SEER 17 population-based registriesJournal of Neuro-Oncology, 2011
- Spatial control of EGF receptor activation by reversible dimerization on living cellsNature, 2010